Connect Biopharma Holdings Ltd Strategic Asset Allocation Index
Connect Biopharma Holdings Ltd strategic asset allocation index. Connect Biopharma Holdings Ltd (CNTB) has a Strategic Asset Allocation Index of 0.0% as of December 2023. Strategic assets (PP&E of $- plus long-term investments of $0.00) total $0.00, measured against net assets of $101.50 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See CNTB equity to assets ratio to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Connect Biopharma Holdings Ltd (2021–2023)
Strategic asset allocation index of Connect Biopharma Holdings Ltd from 2021 to 2023. This chart shows how Connect Biopharma Holdings Ltd's Strategic Asset Allocation Index has evolved across 3 annual periods from 2021 to 2023. As of December 2023, the index stands at 0.0%, representing strategic assets of $0.00 against net assets of $101.50 Million USD. Check Connect Biopharma Holdings Ltd (CNTB) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Connect Biopharma Holdings Ltd Strategic Asset Allocation Index by Year (2021–2023)
Connect Biopharma Holdings Ltd strategic asset allocation index by year from 2021 to 2023. The table below presents the year-by-year Strategic Asset Allocation Index for Connect Biopharma Holdings Ltd from 2021 to 2023, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market value of Connect Biopharma Holdings Ltd.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2023 | 0.0% | $0.00 | $- | $0.00 | $101.50 Million | ▼ -41.7 pp |
| 2022 | 41.7% | $65.74 Million | $- | $65.74 Million | $157.49 Million | ▲ +11.6 pp |
| 2021 | 30.2% | $82.16 Million | $82.16 Million | $0.00 | $272.26 Million | — |